Your browser doesn't support javascript.
loading
Development of a risk grading system to identify patients with acute promyelocytic leukemia at high risk of early death.
Zhang, Yingmei; Hou, Wenyi; Wang, Ping; Hou, Jinxiao; Zhao, Hongli; Jin, Bo; Sun, Jiayue; Cao, Fenglin; Zhao, Yanqiu; Li, Haitao; Ge, Fei; Fu, Jinyue; Zhou, Jin.
Afiliação
  • Zhang Y; Department of Central Laboratory, The First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China, jinzhou1111@gmail.com.
  • Hou W; Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China, jinzhou1111@gmail.com.
  • Wang P; Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China, jinzhou1111@gmail.com.
  • Hou J; Department of Neonatology, The First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China.
  • HuiyuanYang; Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China, jinzhou1111@gmail.com.
  • Zhao H; Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China, jinzhou1111@gmail.com.
  • Jin B; Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China, jinzhou1111@gmail.com.
  • Sun J; Department of Hematology, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China.
  • Cao F; Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China, jinzhou1111@gmail.com.
  • Zhao Y; Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China, jinzhou1111@gmail.com.
  • Li H; Department of Central Laboratory, The First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China, jinzhou1111@gmail.com.
  • Ge F; Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China, jinzhou1111@gmail.com.
  • Fu J; Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China, jinzhou1111@gmail.com.
  • Zhou J; Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China, jinzhou1111@gmail.com.
Cancer Manag Res ; 10: 3619-3627, 2018.
Article em En | MEDLINE | ID: mdl-30271210

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article